SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-18-034065
Filing Date
2018-06-13
Accepted
2018-06-13 16:32:26
Documents
1
Period of Report
2018-06-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv496443_4a.html 4/A  
1 OWNERSHIP DOCUMENT tv496443_4a.xml 4/A 7317
  Complete submission text file 0001144204-18-034065.txt   8745
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLY OAKS ROAD, SUITE 108 WALTHAM MA 02452
Business Address
Wirostko Barbara (Reporting) CIK: 0001669087 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36672 | Film No.: 18897055